mdamb 157 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
96
Structured Review
ATCC
mdamb 157
Mdamb 157, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 588 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mdamb+157/MDA-MB-157/pm39889548-719-8-47
Average 96 stars, based on 588 article reviews
Mdamb 157, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 588 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mdamb+157/MDA-MB-157/pm39889548-719-8-47
Average 96 stars, based on 588 article reviews
mdamb 157 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Multiple Displacement Amplification:Article Title: EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway Article Snippet: .. The human embryonic kidney cell line HEK293, breast cancer cell lines MDA-MB-436, Article Title: SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling. Article Snippet: Triple-negative breast cancer (TNBC) has an aggressive biological behavior and poor outcome.. Our published study showed that PAI-1 could induce the migration and metastasis of TNBC cells.. However, the underlying mechanism by which PAI-1 regulates TNBC metastasis has not been addressed. Article Title: Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3. Article Snippet: .. Human breast cancer cell lines MDA-MB-361 (luminal), MDA-MB-468 (Basal), Article Title: IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells. Article Snippet: Breast cancer is the most prevalent tumor among women as reported by the World Health Organization.. In 2022, the global incidence of breast cancer reached 2.3 million new cases and resulted in 666,000 deaths, cementing it as the second leading cause of cancer-related mortality and a significant threat to human health [1–3].. Triple-negative breast cancer (TNBC) refers to breast cancer that is negative for three molecular markers: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [4, 5]. Article Title: Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomas. Article Snippet: .. MCF7, Article Title: Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy. Article Snippet: Inhibiting the function of transforming acidic coiled-coil 3 (TACC3) offers a promising therapeutic approach for various cancers, such as breast, ovarian, and lung cancers.. Our previous work introduced BO-264 as a novel chemotype for inhibiting TACC3 function, though it exhibited relatively low metabolic stability.. In this study, sixty-two compounds were designed and synthesized to modify the structure of BO-264 to improve its metabolic stability while maintaining its potency. Article Title: Chromatin Accessibility Landscape of Human Triple-negative Breast Cancer Cell Lines Reveals Variation by Patient Donor Ancestry Article Snippet: .. The method assigned a predominant African ancestry to MDA-MB-468, Modification:Article Title: EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway Article Snippet: .. The human embryonic kidney cell line HEK293, breast cancer cell lines MDA-MB-436, Article Title: Synthesis and Identification of Heterobivalent Anticancer Compounds Containing Urea and 5-Arylidene-2-Thiohydantoin Motifs. Article Snippet: Non-small-cell lung cancer cell line A549, breast cancer cell line MDAMB-157, prostate cancer cell line PC3, liver cancer cell line HepG2, and HUVEC were purchased from ATCC. .. A549, Cell Culture:Article Title: Synthesis and Identification of Heterobivalent Anticancer Compounds Containing Urea and 5-Arylidene-2-Thiohydantoin Motifs. Article Snippet: Non-small-cell lung cancer cell line A549, breast cancer cell line MDAMB-157, prostate cancer cell line PC3, liver cancer cell line HepG2, and HUVEC were purchased from ATCC. .. A549, Article Title: IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells. Article Snippet: Breast cancer is the most prevalent tumor among women as reported by the World Health Organization.. In 2022, the global incidence of breast cancer reached 2.3 million new cases and resulted in 666,000 deaths, cementing it as the second leading cause of cancer-related mortality and a significant threat to human health [1–3].. Triple-negative breast cancer (TNBC) refers to breast cancer that is negative for three molecular markers: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [4, 5]. Transformation Assay:Article Title: Stabilizing vimentin phosphorylation inhibits stem-like cell properties and metastasis of hybrid epithelial/mesenchymal carcinomas. Article Snippet: .. MCF7, |